However, emerging research shows immunotherapy can result in different side effects than chemotherapy, including severe adverse events
Research Note: Published preclinical research, including a 2025 literature and patent review in the journal Pharmaceuticals (Jzwiak et al., 2025, Pharmaceuticals ), has documented BPC-157's effects on angiogenesis, nitric oxide signaling, and tissue protection in animal models, though authors note that no completed human clinical trials have been published to confirm these effects in people
Exclusion of other potential causes, such as immune, metabolic, infectious, toxic, and neoplastic conditions, via auxiliary tests
The full 10 day course uses 2 vials
Your 0.25mg dose requires only 5 units on the syringe
In the spotlight Sally Rose - CA May 11, 2023